Amit Senguta <br/><br/>
Biological Drugs: Challenges to Access 

 - Malaysia:  Third World Network,  2018. 
 - 38p. 
<br/><br/><label>ISBN: </label>978-967-0747-26-2 
<br/><br/><label>Subjects--Topical Terms: </label><br/>The Growing Therapeutic and Commercial Importance <br/>How Biological Drugs Differ from Small Molecule Drugs<br/>Recombinant Technologies in the Manufacture of Biological Drugs <br/>Renewed Interest in Biological Medicines <br/>Why are Biologics and Biosimilars So Expensive <br/>Biosimilas vs Generics of SMDs<br/>Technological Barriers to Manufacture of Biosimilars <br/>Barriers Related to Intellectual Property Rights and Data Exclusivity<br/>The Evolving Regulatory Landscape for Approval of Biosimilars <br/>How necessary are Present Requirements to Establish Similarity
<br/><br/><label>Dewey Class. No.: </label>615.32  / AMI